A Sensitive and Selective LC-MS Method for the Determination of Lurasidone in Rat Plasma, Bile, and Urine
- 15 August 2012
- journal article
- Published by Springer Nature in Chromatographia
- Vol. 75 (19-20) , 1117-1128
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in ratsXenobiotica, 2011
- Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychoticInternational Journal Of Clinical Practice, 2010
- Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor ActivityThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Lurasidone: a new drug in development for schizophreniaExpert Opinion on Investigational Drugs, 2009
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysisThe Lancet, 2009
- Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in ratsBehavioural Brain Research, 2008
- Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance testEuropean Journal of Pharmacology, 2007
- Treatment of schizophrenia and spectrum disorders: pharmacotherapy, psychosocial treatments, and neurotransmitter interactionsBiological Psychiatry, 1999
- Positive and negative symptoms of schizophrenia: past, present, and futureActa Psychiatrica Scandinavica, 1994
- Understanding the Mechanism of Action of Atypical Antipsychotic DrugsThe British Journal of Psychiatry, 1993